oral drug products and intermediates

Focus on robust drug product design

We provide integrated design, development and manufacturing services in bioavailability enhancement, modified and targeted drug delivering, and low dose / highly potent applications. Our services are designed to meet the challenges you face in advancing your molecules to the next development milestone. We focus on specialty and enhanced drug products with premier capabilities in bioavailability enhancement and low dose/highly potent applications.

We are uniquely positioned to develop customized approaches in meeting your target product profile. We utilize an integrated product development model, from early stage feasibility and product design through clinical and commercial manufacture of finished drug products –giving our customers the option of a single partner throughout the development to minimize timelines, complexity and risk.

Meet your target product profile

We are uniquely positioned to develop customized approaches in meeting your target product profile. We utilize an integrated product development model, from early stage feasibility and product design through clinical and commercial manufacture of finished drug products–giving our customers the option of a single partner throughout the development to minimize timelines, complexity and risk.

Phase-appropriate services

We start by gaining a full understanding of your compound, target product profile and objectives. Phase-appropriate services and processing are in place so that you get exactly what you need in the timeline required. Whether your requirement is first-in-human, formulation optimization, or rapid scale-up, your next milestone is our focus - let's get there together.

Technologies and products

We have the full range of technologies in-house to address solubility or dissolution rate, modulate drug release, and meet your target product profile. This has enabled us to develop technology selection methodologies based on proprietary databases, predictive models and expert systems to use in place of empirical screening. The result –rapid application of enabling technology to fit a specific compound, thereby accelerating development and clinical timelines while minimizing API requirements.